Covidien announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of SilverHawk/TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities) study.
Biotronik began its European market release of BioMonitor, an implantable cardiac device designed for accurate and reliable monitoring and management of patients with atrial fibrillation (AF) or unexplained syncope.
October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc-99m) generators.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 25, 2012 — InterSystems Corp., a provider of software for healthcare interoperability, and eHealth Technologies, a provider of imaging solutions for electronic health records (EHR) and health information exchange (HIE) solutions, entered a partnership to provide single-click access to diagnostic-quality images via the InterSystems HealthShare strategic informatics platform.
Avinger Inc., a medical device manufacturer of multi-functional catheters for crossing CTOs in patients with peripheral artery disease (PAD), announced its CONNECT II global clinical trial results at the Vascular Interventional Advances (VIVA) Conference 2012 in Las Vegas, Nev.
An online poll of physicians who lead hospitals, health systems and large group practices across the United States conducted after the first presidential debate found more preferred Republican challenger Mitt Romney's plan to reform Medicare than President Barack Obama's, with many still undecided.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 23, 2012 — A study found that a tailored therapy approach that adjusts the loading dose of clopidogrel according to measured platelet reactivity is superior to prasugrel therapy in reducing high platelet reactivity (a risk factor for worse outcomes) in patients with acute coronary syndrome (ACS). Results of the trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
October 23, 2012 — In the DEBATE-SFA trial, researchers found that the use of a paclitaxel drug-eluting balloon (DEB) to widen the artery prior to implanting a self-expanding nitinol stent yielded a lower restenosis rate after one year. Results of the trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the use of the new Gore septal occluder for inclusion in the Gore REDUCE clinical study.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
At RSNA 2012, GE Healthcare will be showcasing a comprehensive portfolio of ultrasound products for use across a broad range of patient exam types. Among the products to be highlighted will be the newly enhanced Logiq E9, Logiq S8 and others in the LOGIQ family.
NEC Display Solutions of America announced the U.S. Food and Drug Administration (FDA) 510(k) market clearance of the 21.3-in MultiSync MD211G3 medical diagnostic, flat panel display for the displaying and viewing of digital mammography images for diagnosis by trained physicians.
QuantiaMD, the largest online physician community, and The International CardiOncology Society (ICOS) announced at the ICOS 6th annual meeting in Milan, Italy a partnership to launch the ICOS global physicians collaboration forum on QuantiaMD. This first-of-its-kind partnership brings together an emerging area of medicine with QuantiaMD’s dynamic clinical exchange to rapidly drive awareness, education and training around the cardiac implications of oncology treatments.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The Transcatheter Cardiovascular Therapeutics (TCT) conference showcases key advancements being made in interventional cardiology, focusing this year on the next generation of drug-eluting stents, bioresorbable stents, patent foramen ovale (PFO) therapy, transcatheter valve therapy and cardiac imaging technologies.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced six-month clinical, IVUS (Intravascular Ultrasound), OCT (Optical Coherence Tomography) and angiographic data for its 15-patient First-In-Man clinical study of the fully bioresorbable drug-eluting scaffold, the DESolve Bioresorbable Coronary Scaffold System at a late-breaking trial session of EuroPCR in Paris.
October 19, 2012 — Volcano Corp. announced it has received both U.S. Food and Drug Administration (FDA) clearance and CE mark to market its new Visions PV .035 digital IVUS catheter in both the United States and Europe.
October 26, 2012
